QuickLinks -- Click here to rapidly navigate through this document

As filed with the Securities and Exchange Commission on May 26, 2004

Registration No. 333-83791



UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549


POST-EFFECTIVE AMENDMENT NO. 1 TO
FORM S-8
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933


BIOTRANSPLANT INCORPORATED
(Exact Name of Registrant as Specified in Its Charter)

Delaware
(State or Other Jurisdiction
of Incorporation or Organization)
  04-3119555
(I.R.S. Employer Identification No.)

c/o Verdolino & Lowey P.C.
124 Washington Street
Suite 101
Foxborough, MA 02035

(Address of Principal Executive Offices)

 

02155
(Zip Code)

1994 Directors' Equity Plan
(Full Title of the Plan)



Copies to:
Keith Lowey
Verdolino & Lowey P.C.
124 Washington Street
Suite 101
Foxborough, MA 02035
Telephone: (508) 543-1720
  Steven Singer, Esq.
Hale and Dorr LLP
60 State Street
Boston, Massachusetts 02109
Telephone: (617) 526-6000





Explanatory Note


        On July 27, 1999, BioTransplant Incorporated ("BioTransplant") filed a registration statement on Form S-8 (File No. 33-83791) registering 50,000 shares of BioTransplant common stock, $.01 par value per share (the "Common Stock"), issued upon the exercise of options granted pursuant to the 1994 Directors' Equity Plan. This registration statement was declared effective on July 27, 1999.

        On February 27, 2003, BioTransplant and its subsidiary, Eligix, Inc., filed voluntary petitions for relief under Chapter 11 of the United States Bankruptcy Code with the United States Bankruptcy Court for the District of Massachusetts (the "Bankruptcy Court"). On April 13, 2004, the Bankruptcy Court entered an order confirming the Chapter 11 liquidating plan (the "Plan"). The effective date of the Plan (the "Effective Date") occurred on April 26, 2004. In accordance with the Plan, as of the Effective Date, all outstanding shares of Common Stock were cancelled.

        This Post-Effective Amendment No. 1 to the Registration Statement on Form S-8 is being filed solely to remove from registration any shares of Common Stock which remain unsold under such Registration Statement as of the date of the Post-Effective Amendment No. 1.




SIGNATURES

        Pursuant to the requirements of the Securities Act of 1933, as amended, the registrant has duly caused this post-effective amendment No. 1 to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Foxborough, Commonwealth of Massachusetts on the 24th day of May, 2004.

    BIOTRANSPLANT INCORPORATED

 

 

By:

 
      /s/  KEITH LOWEY      
Keith Lowey
Trustee*
*
Duly authorized under Section 5 of the Chapter 11 Plan of the Registrant confirmed by Order of the United States Bankruptcy Court for the District of Massachusetts (Chapter 11 Case No. 03-11585) entered April 14, 2004.



QuickLinks

Explanatory Note
SIGNATURES